In a significant development for the life sciences sector, Veeva Systems (NYSE: VEEV) has announced that more than 100 emerging biotech companies have adopted its Veeva Basics platform. This milestone underscores the growing demand for streamlined operational solutions in clinical, regulatory, and quality management, particularly among biotech firms in the U.S. and Europe.

1. Veeva Basics: A Foundation for Growth

Veeva Basics offers a simple, industry-leading solution that enables biotech companies to standardize and simplify their operations. Designed to scale alongside evolving business needs, Veeva Basics leverages pre-configured and pre-validated applications for rapid deployment. Built on the robust Vault Platform, this innovative solution ensures that transitioning to a full Vault setup requires no data migration, which can often be a cumbersome process for growing companies.

Steve Harper, the general manager of Veeva Basics, expressed his enthusiasm for the platform's impact, stating, “More than 100 biotech leaders across 60 companies came together at the Veeva R&D and Quality Summit in Boston to learn, connect, and shape the future of Veeva Basics. We're proud of the impact Veeva Basics is making on emerging biotechs and will continue to add innovative new applications that can be implemented quickly to support the development of new medicines.”

2. New Applications to Enhance Quality Control and Compliance

To further meet the critical needs of biotech companies, Veeva Basics is expanding its offering with two new applications scheduled for release in early 2026:

Veeva LIMS Basics

This application is tailored for virtual companies and will facilitate contract manufacturing organization (CMO) oversight. Key features will include batch release and certificate of analysis (CoA) capabilities, with additional stability functionality expected to be introduced in 2026.

Veeva PromoMats Basics

This solution will provide full content lifecycle management for promotional materials, encompassing approval processes, storage, distribution, and claims management.

By incorporating these applications, Veeva Basics aims to provide biotech firms with the necessary tools to maintain high standards of quality control and compliance as they scale.

3. Testimonials from Satisfied Clients

Veeva Basics has already garnered positive feedback from its users. Richard Tornai, senior director of IT at Structure Therapeutics, emphasized the value of standardizing processes based on industry best practices, saying, “Knowing we have an agile solution that works now, while providing easy access to the Veeva Vault Platform as we grow, gives us peace of mind that we can meet future requirements.”

Similarly, Bryan Ball, chief technical operations officer at Whitehawk Therapeutics, highlighted the importance of a compliant, cost-effective solution for document and record management, noting that Veeva Basics provides logical workflows and a library of standard operating procedures (SOPs) that streamline training.

Bernhard Irlinger, head of quality at AiCuris, praised Veeva Basics for delivering a best-of-breed solution with global support, further affirming Veeva's commitment to innovation and customer success.

4. About Veeva Systems

Veeva Systems is a leading provider of cloud-based solutions for the life sciences industry, delivering software, data, and business consulting services. With over 1,500 clients, including some of the largest biopharmaceutical companies and emerging biotechs, Veeva is dedicated to innovation and excellence in product delivery. The company operates as a Public Benefit Corporation, balancing the interests of its stakeholders, including customers, employees, and shareholders.

For more information on Veeva Basics and its offerings, interested parties can visit veevabasics.com.

As the biotech sector continues to evolve, Veeva Systems is poised to remain at the forefront, providing essential tools and support for the next generation of medical innovation.

Original press release